Evidence map›Paper›PMID 22768212›Full record

ArticlePloS one2012

Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy.

Christopher R Sudfeld, Molin Wang, Said Aboud, Edward L Giovannucci, Ferdinand M Mugusi, Wafaie W Fawzi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Micronutrient supplementation in adults with HIV infection.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Pooled it
  3. Trial
  4. Efficacy of vitamin DThe lancet. HIV · 2020
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Changes in Bone Mineral Density, Body Composition, Vitamin D Status, and Mineral Metabolism in Urban HIV-Positive South African Women Over 12 Months.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Trial
  9. Trial
  10. Efficacy of vitamin DTrials · 2017
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Christopher R SudfeldDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America. csudfeld@hsph.harvard.edu
Molin Wang
Said Aboud
Edward L Giovannucci
Ferdinand M Mugusi
Wafaie W Fawzi
Harvard University · USMuhimbili University of Health and Allied Sciences · TZBrigham and Women's Hospital · US

Funding

BIOSTATISTICS/EPIDEMIOLOGY TRAINING GRANTS IN AIDST32AI007358 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Michael David Hughes · 1989 to 2026
$12.4M
TRIALS OF VITAMINS IN HIV PROGRESSION AND TRANSMISSIONR01HD032257 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI FAWZI, WAFAIE W · 1994 to 2009
$5.5M
NIAID NIH HHS T32 AI007358NIAID NIH HHS T32AI007358NICHD NIH HHS R01 HD032257NICHD NIH HHS R01 HD32257
6 · The paper itself

Abstract

backgroundThere is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa.

methodsSerum 25-hydroxyvitamin D (25(OH)D) levels were assessed at ART initiation for a randomly selected cohort of HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania during 2006-2010. Participants were prospectively followed at monthly clinic visits for a median of 20.6 months. CD4 T-cell measurements were obtained every 4 months. Proportional hazard models were utilized for mortality analyses while generalized estimating equations were used for CD4 T-cell counts.

resultsSerum 25(OH)D was measured in 1103 adults 9.2% were classified as vitamin D deficient (<20 ng/ml), 43.6% insufficient (20-30 ng/mL), and 47.2% as sufficient (>30 ng/mL). After multivariate adjustment, vitamin D deficiency was significantly associated with increased mortality as compared to vitamin D sufficiency (HR: 2.00; 95% CI: 1.19-3.37; p = 0.009), whereas no significant association was found for vitamin D insufficiency (HR: 1.24; 95% CI: 0.87-1.78; p = 0.24). No effect modification by ART regimen or change in the associations over time was detected. Vitamin D status was not associated with change in CD4 T-cell count after ART initiation.

conclusionsDeficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.

Indexed as

Antiretroviral Therapy, Highly ActiveDisease ProgressionAdultAnti-HIV AgentsCD4 Lymphocyte CountCohort StudiesFemaleHIV InfectionsHumansKaplan-Meier EstimateMaleProportional Hazards ModelsRisk FactorsTanzaniaVitamin DAnti-HIV AgentsVitamin D

Identifiers

PMID22768212
PMCPMC3386915
OpenAlexW1977430952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.